Guan (2020)
Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098485/
Comorbidities
Cancer (Present vs. Not present)
COVID-19 (severe/critical)
Hazard ratio: 3.500 (1.600-7.640) Univariate analysis

Retrospective observational study

1590

575 hospitals in China, from November 21st, 2019 to January 31st, 2020

Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis

0


COVID-19 (severe/critical)

0

COVID-19 (critical)


Comorbidities

Cancer

Not present

Present


Hazard ratio

3.500 (1.600-7.640)

No

Yes

No


No